[go: up one dir, main page]

AU2002229976A1 - Imidazopyridines - Google Patents

Imidazopyridines

Info

Publication number
AU2002229976A1
AU2002229976A1 AU2002229976A AU2002229976A AU2002229976A1 AU 2002229976 A1 AU2002229976 A1 AU 2002229976A1 AU 2002229976 A AU2002229976 A AU 2002229976A AU 2002229976 A AU2002229976 A AU 2002229976A AU 2002229976 A1 AU2002229976 A1 AU 2002229976A1
Authority
AU
Australia
Prior art keywords
imidazopyridines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229976A
Inventor
Alexander Graham Dossetter
Peter Kenny
Darren Mckerrecher
Michael Wardleworth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002229976A1 publication Critical patent/AU2002229976A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002229976A 2001-02-20 2002-02-15 Imidazopyridines Abandoned AU2002229976A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100567-7 2001-02-20
SE0100567A SE0100567D0 (en) 2001-02-20 2001-02-20 Compounds
PCT/GB2002/000634 WO2002066477A2 (en) 2001-02-20 2002-02-15 Imidazopyridines

Publications (1)

Publication Number Publication Date
AU2002229976A1 true AU2002229976A1 (en) 2002-09-04

Family

ID=20283057

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229976A Abandoned AU2002229976A1 (en) 2001-02-20 2002-02-15 Imidazopyridines

Country Status (3)

Country Link
AU (1) AU2002229976A1 (en)
SE (1) SE0100567D0 (en)
WO (1) WO2002066477A2 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10246890A1 (en) * 2002-10-08 2004-04-22 Grünenthal GmbH New C-(imidazo-(1,2-a)-pyridin-3-yl)-methylamines, are nitrogen monoxide synthase inhibitors useful e.g. for treating migraine, septic shock, neurodegenerative diseases, inflammatory pain or cancer
DE10247271A1 (en) * 2002-10-10 2004-08-26 Grünenthal GmbH Use of new and known 7-(methyl or trifluoromethyl)-imidazo-(1,2-a)-pyridines as nitrogen monoxide synthase inhibitors useful e.g. for treating migraine, neurodegenerative diseases, inflammatory pain, diabetes or cancer
GB0320806D0 (en) 2003-09-05 2003-10-08 Astrazeneca Ab Therapeutic treatment
JP2007509960A (en) 2003-10-28 2007-04-19 セプラコア インコーポレーテッド Imidazo [1,2-a] pyridine anxiolytic
GB0403781D0 (en) * 2004-02-20 2004-03-24 Astrazeneca Ab Chemical compounds
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
MX2007000481A (en) 2004-07-14 2007-03-29 Ptc Therapeutics Inc Methods for treating hepatitis c.
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (en) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Thienopyridine for treating hepatitis C
JPWO2007069565A1 (en) 2005-12-12 2009-05-21 小野薬品工業株式会社 Bicyclic heterocyclic compounds
JP2009531390A (en) * 2006-03-31 2009-09-03 ノバルティス アクチエンゲゼルシャフト Organic compounds
WO2008027812A2 (en) 2006-08-28 2008-03-06 Forest Laboratories Holdings Limited Imidazopyridine and imidazopyrimidine derivatives
WO2008032764A1 (en) 2006-09-13 2008-03-20 Kyowa Hakko Kirin Co., Ltd. Fused heterocyclic derivative
JP5442449B2 (en) 2006-12-22 2014-03-12 アステックス、セラピューティックス、リミテッド New compounds
US8895745B2 (en) 2006-12-22 2014-11-25 Astex Therapeutics Limited Bicyclic heterocyclic compounds as FGFR inhibitors
EP1964840A1 (en) 2007-02-28 2008-09-03 sanofi-aventis Imidazo[1,2-a]pyridines and their use as pharmaceuticals
KR101538179B1 (en) 2007-04-03 2015-07-20 어레이 바이오파마 인크. Imidazo [1,2-a] pyridine < / RTI > compounds as receptor tyrosine kinase inhibitors
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
EP2213672A4 (en) * 2007-10-24 2012-05-02 Nihon Mediphysics Co Ltd NOVEL COMPOUND HAVING AFFINITY TO AN AMYLOID SUBSTANCE
JP5774982B2 (en) * 2008-05-19 2015-09-09 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． Imidazo [1,2-a] pyridine compound
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
JP5931752B2 (en) 2011-02-01 2016-06-08 協和発酵キリン株式会社 Fused heterocyclic derivatives
US8975276B2 (en) 2011-06-29 2015-03-10 Bristol-Myers Squibb Company Inhibitors of PDE10
UY34305A (en) 2011-09-01 2013-04-30 Novartis Ag DERIVATIVES OF BICYCLIC HETEROCICLES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
US9540366B2 (en) 2012-07-31 2017-01-10 Kyowa Hakko Kirin Co., Ltd. Ring-fused heterocyclic compound
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
US20170107216A1 (en) 2015-10-19 2017-04-20 Incyte Corporation Heterocyclic compounds as immunomodulators
SG11201804152RA (en) 2015-11-19 2018-06-28 Incyte Corp Heterocyclic compounds as immunomodulators
MA44075A (en) 2015-12-17 2021-05-19 Incyte Corp N-PHENYL-PYRIDINE-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS MODULATORS OF PROTEIN / PROTEIN PD-1 / PD-L1 INTERACTIONS
EP3828171A1 (en) 2015-12-22 2021-06-02 Incyte Corporation Heterocyclic compounds as immunomodulators
US9926316B2 (en) 2016-03-03 2018-03-27 The Cleveland Clinic Foundation Antitumor derivatives for differentiation therapy
AR108396A1 (en) 2016-05-06 2018-08-15 Incyte Corp HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
TW201808902A (en) 2016-05-26 2018-03-16 美商英塞特公司 Heterocyclic compounds as immunomodulators
AU2017281285C1 (en) 2016-06-20 2022-05-12 Incyte Corporation Heterocyclic compounds as immunomodulators
EP3484866B1 (en) 2016-07-14 2022-09-07 Incyte Corporation Heterocyclic compounds as immunomodulators
EP3504198B1 (en) 2016-08-29 2023-01-25 Incyte Corporation Heterocyclic compounds as immunomodulators
PE20200005A1 (en) 2016-12-22 2020-01-06 Incyte Corp DERIVATIVES OF TETRAHYDRO IMIDAZO [4,5-C] PYRIDINE AS INDUCTORS OF INTERNALIZATION PD-L1
EP3558989B1 (en) 2016-12-22 2021-04-14 Incyte Corporation Triazolo[1,5-a]pyridine derivatives as immunomodulators
IL295660A (en) 2016-12-22 2022-10-01 Incyte Corp Benzoxazole derivatives as immunomodulators
US20180179179A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2018119286A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Bicyclic heteroaromatic compounds as immunomodulators
KR20250067967A (en) 2018-03-30 2025-05-15 인사이트 코포레이션 Heterocyclic compounds as immunomodulators
HUE061503T2 (en) 2018-05-11 2023-07-28 Incyte Corp Tetrahydroimidazo[4,5-C]pyridine derivatives as PD-L1 immunomodulators
EP4010342A1 (en) 2019-08-09 2022-06-15 Incyte Corporation Salts of a pd-1/pd-l1 inhibitor
TWI879811B (en) 2019-09-30 2025-04-11 美商英塞特公司 Pyrido[3,2-d]pyrimidine compounds as immunomodulators
PH12022551136A1 (en) 2019-11-11 2023-10-09 Incyte Corp Salts and crystalline forms of a pd-1/pd-l1 inhibitor
CN116670114A (en) 2020-11-06 2023-08-29 因赛特公司 Methods for preparing PD-1/PD-L1 inhibitors, and salts and crystalline forms thereof
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
TW202233615A (en) 2020-11-06 2022-09-01 美商英塞特公司 Crystalline form of a pd-1/pd-l1 inhibitor
CN113666926A (en) * 2021-09-08 2021-11-19 桂林理工大学 A Facile Michal Addition of 2-phenylimidazo[1,2-a]pyridine to Chalcone

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19544212A1 (en) * 1995-11-28 1997-06-05 Asta Medica Ag New LH-RH antagonists with improved effects
ATE338754T1 (en) * 1996-07-19 2006-09-15 Takeda Pharmaceutical HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE
AU9621598A (en) * 1997-10-20 1999-05-10 Novo Nordisk A/S Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive
CA2318957A1 (en) * 1998-02-11 1999-08-19 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
AU2597299A (en) * 1998-02-11 1999-08-30 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US6608197B2 (en) * 2000-01-25 2003-08-19 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
CA2407573C (en) * 2000-04-27 2011-09-13 Yamanouchi Pharmaceutical Co. Ltd. Imidazopyridine derivatives

Also Published As

Publication number Publication date
WO2002066477A3 (en) 2002-10-17
WO2002066477A2 (en) 2002-08-29
SE0100567D0 (en) 2001-02-20

Similar Documents

Publication Publication Date Title
AU2002229976A1 (en) Imidazopyridines
AU2002352142A1 (en) Pyrazolopyridine derivatives
AU2002313565A1 (en) Putter-heads
AU2002308154A1 (en) Triazolopyrimidines
AU2002319532A1 (en) Feeding-bottles
AU2002313943A1 (en) Electromobile
AU2002226571A1 (en) Biligands
AU2002233664A1 (en) Naphthyridine derivative
AU2001100406A4 (en) DriverSMS
AU2002313073A1 (en) Phytocystatin
AU2002257925A1 (en) Numberplates
HK1063470A (en) Azaindoles
AU2001100532A4 (en) FonePark
AU2002100746A4 (en) Adrail
AU2001100338A4 (en) Sunglove
AU2001100214A4 (en) Dolly-trolley
AU2001100522A4 (en) e-Trans
AU2002221442A1 (en) Aminoacid-iodine complex
AU2002304671A1 (en) Triazolopyrimidines
AU2002317000A1 (en) Morpholine-bridged pyrazolopyridine derivatives
AU2002249693A1 (en) Starseparator
AU2002312925A1 (en) 5-ethyl-imidazotriazinones
AU2001235574A1 (en) Ring-mouse
AU2002253687A1 (en) Floss-pick
AU2002256542A1 (en) Motor-vehicle-tank-sender-unit

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase